Bodybuilders and others who wish to boost muscle growth can utilize Dindolyl Methane (or DIM). Recent research has shown that DIM could pose health hazards. DIM can cause liver damage if taken in excessive amounts. Kidney damage is also a concern, and may lead to kidney failure. The possible long term health risks associated with DIM cause many athletes and bodybuilders ask the question: should I supplement my diet with supplements with DIM?
The majority of people take diindolylmethane as a supplement to increase the production of testosterone. It is well-known that testosterone functions as an androgen. This means that it can trigger hormonal changes within the tissues. DIM has been shown in studies to mimic the effects of testosterone, and other hormones. Some manufacturers have added diindolylmethane (DIM) to their products to boost their popularity in male circles, as men produce more testosterone than women do. The idea is that men will respond to a product which replicates the effects of testosterone naturally produced.
In the end, many companies advertise DIM as a cancer-fighter. Although diindolylmethane can be effective in reducing tumor growth in laboratory animals, it was given orally to these animals. In order for humans to experience the same effect diindolylmethane needs to be taken in high doses for a long time. The animals that were examined had no indications of cancer for a number of years. However, they all developed liver disease after consuming too much diindolylmethane. A doctor can give you an understanding of the way DIM functions within the body.
The only way to prove that DIM is effective in treating breast carcinoma is to do an experiment in which cells from healthy breast cells are exposed to high doses of diindolylmethane over a prolonged period of time. Like all chemicals, there are both pros and cons associated with using it. Its advantages include the capability to mimic hormones. This means that you could make insulin, which could inhibit cancer cell proliferation. The downsides are that diindolylmethane can also produce the potentially harmful chemical DMSO. Read more about dim diindolylmethane supplement now.
One of the most commonly used claims about diindolylmethane’s usage as treatment for various illnesses is that it acts as an natural, antibacterial, anticancer and anti-fungal agent. The National Institute of Health, through an exhaustive review of the supporting evidence concluded that there was no basis for these claims. According to the Institute of Chemical Technology there were no experiments that support this claim. The Institute of Chemical Safety, conducting an in-depth study of the safety profile for the firestone concluded that the data presented by pharmaceutical companies about the benefits of diindolylmethane for humans was not completely reliable.
In a May 2021 edition of the Journal of Toxicology and Environmental Health, van der Goes, and colleagues. identified a variety of potential dangers related to diindolylmethane’s use, such as allergic reactions, skin rash, asthma attacks, dizziness, headaches, and respiratory ailments. They also noted that the recommended daily dose for this chemical is 0.2 milligrams or one tenth of one teaspoon. It is not known what the concentration will be when this chemical is mixed with other compounds. Since this substance hasn’t been thoroughly tested, it is not considered to be safe at any level.
The abstract of the view shows that diindolylmethane’s use in cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism through flavenoids is a possibility to block and stops the accumulation of the pyruvate metabolites and oxalates in renal tubule cells. However, the metabiplicate drug toxicology studies did not provide convincing evidence that the consumption of this chemical causes an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the company that makes firestone tincture is in the process of conducting two major studies – one in Europe and one in the United States.
The view abstract also shows the use of diindolylmethane in cancer treatment is based on the concept of inhibiting intracellular inhibition via flavenoids of pyruvate metabolism , and thus preventing the accumulation of adenine and oxalates within renal tubule cells. However, the drug metabiplicate toxicology studies did not provide evidence convincing that consumption of this chemical can cause an overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA the company that makes firestone Tincture is in the process of completing two major trials in Europe and the United States. According to the FDA the company that produces firestone tincture is in process of finishing two major trials in Europe and one in the United States.